BSECompany Update2d ago · 27 Jul 2026, 12:03 pm
Intimation for Earnings call to be held on Wednesday, 5th August 2026
Sudeep Pharma Ltd · 544619
✦ AI SummaryResults
Sudeep Pharma Ltd schedules earnings call with analysts/investors on August 5, 2026, to discuss Q1FY27 financial results.
Analysis Scores
Earnings Impact8/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact9/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sudeep Pharma Ltd - 544619 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
dc7e89c3-990e-443e-8b51-755e9f1877ff.pdf
View document text
Date: 27th July 2026
National Stock Exchange of India Limited BSE Limited Phiroze Jeejeebhoy Towers
Exchange Plaza, C-1, Block G Bandra Kurla Dalal Street, Mumbai – 400001
Complex, Bandra (E), Mumbai – 400051 Scrip Code: 544619
Scrip Symbol- SUDEEPPHRM
Sub: Intimation of Earnings Call with Analysts/Investors on 5th August 2026
Ref: Regulation 30 of the SEBI Listing Regulations, 2015
Dear Sir/Ma’am,
This is to inform that the “Earnings Call” of the Company with Analysts/Investors to discuss
the operational & financial performance for the quarter ended on 30th June 2026, is scheduled
as below:
Day & Date: Wednesday, 5th August 2026
Time: 11:00 a.m.
Registration Link and Access numbers: As per Annexure
Copy of Earnings Call invite is annexed herewith and is also hosted on our website
https://www.sudeeppharma.com/investor-relations/financial-results/#concall-invitation
Kindly take the same on record.
Thanking You.
For Sudeep Pharma Limited
Dimple Mehta
Company Secretary & Compliance Officer
M. No.: F13184
ENCL: A/a
CIN: L24231GJ1989PLC013141
Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India.
Phone No.: +91 265 2840656, 7624095107
Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat,
India Website: www.sudeepgroup.com, Email ID: mail@sudeepgroup.com
CONFERENCE CALL
SUDEEP PHARMA LIMITED
Hosted by Nuvama Wealth Management
India Equity Research July 27, 2026
Nuvama Wealth Management is hosting a conference call with the management of Sudeep Pharma Limited to
discuss the Company’s Q1FY27 financial results on Wednesday, August 05, 2026 at 11.00 AM IST.
Mr. Sujit Bhayani – Managing Director, Mr. Shanil Bhayani – Director, Mr. Ketan Vyas – Chief Financial Officer will
represent on the call.
Details of the conference call are as under:
Time : 11.00 AM IST on Wednesday, August 05, 2026
Conference dial-in:
India : Mumbai
: Primary access number + 91 22 6280 1123
+91 22 7115 8024
USA : 1 866 746 2133
UK : 0 808 101 1573
Singapore Toll Free No. : 800 101 2045
Hong Kong Toll Free No. : 800 964 448
Call leader Mr. Archit Joshi
For further information, please contact:
Archit Joshi
Nuvama Wealth Management Ltd.
E-mail: Archit.Joshi@nuvama.com
Express Join with DiamondPass™
Nuvama Research is also available on research.nuvama.com, Bloomberg – NUVA, Thomson Reuters and Factset Nuvama Wealth Management Ltd.